Reach Us +1-217-403-9671
Enhancement Of Bioavailability Of Aceclofenac Using Solid Dispersion Technique | 8411
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Enhancement of Bioavailability of Aceclofenac using Solid Dispersion Technique

International Conference & Exhibition Bioequivalence and Bioavailability

Dua Kamal, Sara U.V.S, D.K. Agrawal, Sharma V.K. Pabreja K.

ScientificTracks Abstracts: J Bioequiv Availab

DOI: 10.4172/0975-0851.1000001

A ceclofenac is a poorly water-soluble, new generational non- steroidal anti-inflammatory drug. The aim of the present work was to investigate and compare the effect of PVP K-30 and PVP/VA 64 as carriers on in vitro dissolution characteristics of aceclofenac. Aceclofenac solid dispersions were prepared by fusion method. All the prepared solid dispersions exhibited appropriate yield, average particle size, drug content, wetting time and moisture content. Scanning electron microscopy indicated the amorphous nature of the drug in the prepared formulation. The carriers did not show any incompatibility when tested using Fourier transform infrared spectroscopy and differential scanning calorimetry. A higher release in both, 0.1 N HCl, pH 1.2 and phosphate buffer, pH 7.4 was observed as compared to pure drug and their corresponding physical mixtures. With perspective of the dissolution media, the phosphate buffer, pH 7.4 showed higher dissolution as compared to 0.1 N HCl, pH 1.2. The highest improvement in dissolution was found with PVP K-30 as carrier. The in vitro release from all the formulations was best described by first order kinetics (R 2 = 0.9354 and 0.9268 in 0.1N HCl and phosphate buffer, respectively) followed by Higuchi release model (R 2 = 0.9029 and 0.9578 in 0.1N HCl and phosphate buffer, respectively) with better intestinal absorption, analgesic and anti-inflammatory activity ( p < 0.05). The intestinal absorption followed the first order kinetics (Rv 2 = 0.9408). With enhanced solubility and dissolution, it is expected that aceclofenac in solid dispersions will demonstrate improved bioavailability.